Skip to main content
Log in

Effects of peptide Pro-Gly-Pro-Leu under conditions of normal hemostasis and thrombus formation in rats

  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

Tetrapeptide Pro-Gly-Pro-Leu in vitro effectively inhibited platelet aggregation over the entire range of studied concentrations (10−12–10−3 M). In concentrations of 10−9–10−3 M it exhibits fibrinolytic activity and in concentrations of 10−5–10−3 M has anticoagulant properties. Under in vivo conditions the analyzed tetrapeptide in a dose of 1 mg/kg increased anticoagulant, total and fibrin depolymerizating activities and increased activity of plasminogen activator. Intravenous administration produced more pronounced anticoagulant effect and leads to a greater increase in activity of plasminogen activator than intranasal administration. Tetrapeptide Pro-Gly-Pro-Leu also exerts antithrombotic effect. Preliminary repeated intranasal administration of the peptide before blood clot formation reduces the weight of fresh fibrin clots.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. I. P. Ashmarin, A. A, Kamenskii, and L. A. Lyapina, Vopr. Biol. Med. Farm. Khimii, No. 1, 24–27 (2002).

  2. I. P. Ashmarin, E. P. Karazeeva, L. A. Lyapina, and G. E. Samonina, Biokhimia, 63, No. 2, 149–155 (1998).

    Google Scholar 

  3. Z. S. Barkagan and A. P. Momot, Diagnosis and Controlled Therapy of Hemostasis Disorders [in Russian], Moscow (2001).

  4. A. L. Berkovskii, S. A. Vasilyev, L. V. Zherdeva, et al., A Manual for the Study of Platelet Adhesion-Aggregation Activity [in Russian], Moscow, 2001, 22–28.

  5. T. V. Vyunova, K. V. Shevchenko, V. P. Shevchenko, et al., Dokl. Akad. Nauk, 419, No. 1, 136–137 (2008).

    Google Scholar 

  6. V. V. Dolgov, N. A. Avdeeva, and K. A. Shchetnikovich, Methods for Studying Hemostasis. A Manual for Physicians of Clinical Laboratory Diagnostics [in Russian], Moscow (1990), pp. 9–10.

  7. L. A. Lyapina, V. E. Pastorova, T. Y. Smolina, and I. P. Khomenko, Herald of Moscow State University. Ser. Biol., No.1, 3–6 (2003).

  8. N. L. Sheremet, G. S. Polunin, A. N. Ovchinnikov, et al., Vestn. Oftalmol., 120, No. 6, 25–27 (2002).

    Google Scholar 

  9. A. Duttaroy, P. Kanakaraj, and B. L. Osborn, et al., Diabetes, 54, No. 1, 251–258 (2005).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to D. L. Rochev.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 152, No. 8, pp. 144–147, August, 2011.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Obergan, T.Y., Rochev, D.L. & Lyapina, L.A. Effects of peptide Pro-Gly-Pro-Leu under conditions of normal hemostasis and thrombus formation in rats. Bull Exp Biol Med 152, 184–187 (2011). https://doi.org/10.1007/s10517-011-1483-9

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-011-1483-9

Keywords

Navigation